Lucid Diagnostics Inc. (LUCD) has 5 open-market insider trades by 3 insiders since 2021. Over the last six months insiders net bought $245K. The most active filer is Dennis Matheis, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| PAVmed Inc. | 10% Owner | — | 1 | $8.0M | 2024-02-15 |
| Dennis Matheis | Dir | — | 3 | $1.2M | 2026-05-20 |
| Stanley Lapidus | Dir | — | 1 | $58K | 2026-02-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Dennis Matheis | Director | Buy | $245K | 2026-05-20 |
| Dennis Matheis | Director | Buy | $102K | 2025-08-20 |
| Dennis Matheis | Director | Buy | $873K | 2025-05-20 |
| Stanley Lapidus | Director | Sell | $43K | 2023-09-25 |
| Stanley Lapidus | Director | Sell | $6K | 2023-09-20 |
| Stanley Lapidus | Director | Sell | $58K | 2022-09-20 |
Companies that share insiders with LUCD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| PAVmed Inc. | 10% Owner | Buy | $8.0M | 2021-10-18 |